Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial-Reference-Cited by-同舟云学术

Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial

Published:2019-03-07 Issue:Supplement_2 Volume:68 Page:S67-S73
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Theiss-Nyland Katherine¹,Shakya Mila¹,Colin-Jones Rachel¹,Voysey Merryn¹,Smith Nicola¹,Karkey Abhilasha²,Dongol Sabina²,Pant Dikshya²,Farooq Yama G¹,Neuzil Kathleen M³,Shrestha Shrijana⁴,Basnyat Buddha²,Pollard Andrew J¹

Affiliation:

1. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom

2. Oxford University Clinical Research Unit–Nepal, Patan Hospital, Kathmandu

3. Center for Vaccine Development and Global Health at the University of Maryland, Baltimore, MD

4. Paediatric Research Unit, Patan Hospital, Kathmandu, Nepal

Funder

Bill and Melinda Gates Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link